Iris Roth
Chief Operating Officer, Zentalis Pharmaceuticals, Inc.
Companies
- Zentalis Pharmaceuticals, Inc.Chief operating officer Feb 13, 2023 to Mar 2, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Zentalis Pharmaceuticals, Inc. ZNTL52,500 shares2$120.2K at $2.29Mar 1, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 1, 2023Granted 52,500 shares of Zentalis Pharmaceuticals, Inc.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2